ADH has a very substantial chance for breast cancer when coupled with BIRADS IV/V and substantial breast tissue quantity. ADH on core biopsy may possibly depict inadequately sampled DCIS. Inside a current randomized controlled trial, MRI within the extremely dense breast screening team with a